Champions Oncology, Inc. (CSBR)
NASDAQ: CSBR · Real-Time Price · USD
10.17
-0.32 (-3.05%)
Feb 21, 2025, 4:00 PM EST - Market closed
Champions Oncology Employees
Champions Oncology had 210 employees as of April 30, 2024. The number of employees decreased by 20 or -8.70% compared to the previous year.
Employees
210
Change (1Y)
-20
Growth (1Y)
-8.70%
Revenue / Employee
$255,100
Profits / Employee
-$2,848
Market Cap
139.32M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 72,000 |
CSBR News
- 4 days ago - Champions Oncology Announces 17 Abstracts Accepted for Presentation at the 2025 American Association for Cancer Research Annual Meeting - Accesswire
- 6 weeks ago - Champions Oncology Enhances Clinical Bioanalytical Services Portfolio with New Technology and Additional Leadership - Accesswire
- 2 months ago - Champions Oncology: Right Point To Own In The Cycle Thanks To Operating Efficiencies - Seeking Alpha
- 2 months ago - Champions Oncology, Inc. (CSBR) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Champions Oncology Reports Quarterly Revenue of $13.5 Million Adjusted EBITDA of $1.1 Million - Accesswire
- 2 months ago - Champions Oncology to Announce Second Quarter Financial Results on Wednesday, December 11, 2024 - Accesswire
- 4 months ago - Champions Oncology Announces Agreement with Weill Cornell Medicine - Accesswire
- 5 months ago - Champions Oncology, Inc. (CSBR) Q1 2025 Earnings Call Transcript - Seeking Alpha